New Study Confirms Ivermectin Outperforms Other Options

Hardly any other time in history has such fear been sparked around the world as it has been in 2020 and 2021. The depth and breadth of the strategies used to fuel those fears has been overwhelming.

Emergency use consents for drugs that have not been shown to be effective in trials1,2 public mask mandates for which there is no scientific evidence3,4,5 and the suppression and censorship of health information have fueled public fears of a viral disease with a survival rate of more than 99%,6

Unfortunately, many of the early effective treatment strategies that can be used at home have also fallen victim to censorship. Ivermectin is one of those strategies. In a computational analysis of the Omicron variant against several therapeutic agents, data shows that ivermectin had the best results.7

But if you look objectively at what is happening around the world, the fear that is being generated is not one-sided. The suppression of information by companies, government agencies and the pharmaceutical industry is an indication of their concern and how far they are willing to go to ensure that the level of fear remains high enough to manipulate behavior.

Take a look at the statistics from the US Centers for Disease Control and Prevention. In 2019, 4.6% of the US population was diagnosed with heart disease.8 At the end of 2019, the population was 328,239,523.9 This means that in 2019 there were 15,099,018 people with heart disease in the US. disease,10 which is a death rate of 4.6%.

This is 20 times higher than the death rate from COVID-19. Yet these same agencies did not lobby for mandates against soda or sugar-laden foods; they didn’t ban smoking and they didn’t mandate exercise – all risk factors for heart disease

The censorship and suppression of information has hindered early treatment of COVID-19 in many Western countries. Until 2020, public health experts12,13 and the mainstream media14,15 warned against the use of hydroxychloroquine and ivermectin. Both are on the World Health Organization’s list of essential drugs16, but the benefits have been ignored by public health officials and buried by the media.

Latest ivermectin study showed best results against COVID

This study on Cornell University’s preprint website has not yet been peer-reviewed. Researchers used computational analysis to look at the Omicron variant, which has shown lower clinical presentation and lower hospitalization rates.17

After retrieving the full genome sequence and collecting 30 variants from the database, the researchers analyzed 10 drugs against the virus, including:

Nirmatrelvir

Ritonvir

ivermectin

lopinavir

Boceprevir

MPro 13b

MPro N3

GC-373

GC376

PF-00835231

The researchers found that each of the drugs had some degree of effectiveness against the virus, and most of them are currently in clinical trials. They used molecular linkage to find that the mutations in the Omicron variant did not significantly affect the interaction between the drugs and the main protease.

An analysis of all 10 drugs found that ivermectin was the most effective drug candidate against the Omicron variant. The tests include Nirmatrelvir (Paxlovid), the new protease inhibitor for which the FDA granted emergency use approval for use against COVID in December 2021.18

In other words, Pfizer released a new drug that cost US taxpayers $5.29 billion or $529 per course of treatment19 and received an EUA despite the availability of a similar drug that has been shown to be more effective and cheaper, priced between $4,820 and $4,820. $9521. for 20 pills, depending on your location.

How ivermectin works

Ivermectin is best known for its antiparasitic properties.22 However, the drug also has antiviral and anti-inflammatory properties. Studies have shown that ivermectin helps lower viral load by inhibiting replication.23 A single dose of ivermectin can kill 99.8% of the virus within 48 hours.24

A meta-analysis in the American Journal of Therapeutics25 showed that when used preventively, the drug reduced infection by an average of 86%. An observational study26 in Bangladesh evaluated the effectiveness of ivermectin as a prophylaxis for COVID-19 in health professionals.

The data showed that four of 58 volunteers who took 12 mg of ivermectin once a month for four months developed mild COVID symptoms compared to 44 of 60 health professionals who declined the medication.

Ivermectin has also been shown to accelerate recovery, including by inhibiting inflammation and protecting against organ damage.27 This pathway also reduces the risk of hospitalization and death. Meta-analyses have shown an average mortality reduction ranging from 75%28 to 83%.29,30

In addition, the drug also prevents the transmission of SARS-CoV-2 when taken before or after exposure.31 Taken together, these benefits make it clear that ivermectin could virtually eliminate this pandemic.

Early intervention reduces long-term COVID and hospitalization

Some people who have had COVID-19 do not seem to be able to make a full recovery and complain of persistent symptoms of chronic fatigue. Others struggle with mental health issues. One study, 32.33 in November 2020, found that 18.1% of people with COVID-19 received their first psychiatric diagnosis within 14 to 90 days of recovery. The most commonly diagnosed conditions were anxiety disorders, insomnia and dementia.

These symptoms are called lung covid, long-haul COVID, post-COVID syndrome, chronic COVID, or long-haul syndrome. They all refer to symptoms that persist for four weeks after an initial COVID-19 infection. According to Dr. Peter McCullough, board-certified internist and cardiologist, 50% of those who have been sick enough to be hospitalized will have symptoms of long-term COVID:34

“So the sicker a person is and the longer the duration of COVID, the more likely they are to have long-term COVID syndrome. That’s why we like early treatment. We shorten the duration of symptoms and there is less chance of long-term COVID syndrome.”

Some common symptoms of long-term COVID include shortness of breath, joint pain, problems with memory, concentration, or sleep, muscle aches or headaches, and loss of smell or taste. According to McCullough, a paper presented by Dr. Bruce Patterson at the International COVID Summit in Rome, September 11 to 14.35 2021:36

“… showed that in individuals who have had significant COVID disease, the s1 segment of the spike protein can be recovered from human monocytes 15 months later. That means the body has literally been sprayed with the virus and it takes, in a sense, 15 months to clear the spike protein from our tissues. No wonder people have long-term COVID syndrome.”

It should come as no surprise that studies have also confirmed that early intervention improves mortality37 and reduces hospitalizations.38 Perhaps one of the greatest crimes in this entire pandemic has been the refusal by the governing health authorities to provide guidelines for early treatment.

Instead, they’ve done everything possible to suppress remedies that have been shown to work. Patients were simply told to stay home and do nothing. When the infection had progressed to the point of near-death, the patients were told to go to the hospital, where most were routinely placed on mechanical ventilation — a practice that was soon found to be fatal.

However, as the recommended study39 and others have shown40, ivermectin is one of the successful treatment protocols that can be used against SARS-CoV-2.

Africa has the lowest case and death rate, probably of ivermectin

Around the world, countries have taken different approaches to tackle the spread of the virus.41 The steps taken in Africa varied by country, but infection and death rates were relatively stable and low across the continent.42

In the past year, there have been reports of small areas of the world where the number of infections, deaths or deaths has been significantly lower than in the rest of the world. For example, the Indian state of Uttar Pradesh43 reported a recovery rate of 98.6% and no further infections.

However, the entire continent of Africa seems to have sidestepped the sheer number of infections and deaths predicted for these poorly funded countries with overcrowded cities. Early estimates were that millions would die, but that scenario has not materialized. The World Health Organization has called Africa “one of the least affected regions in the world”.44

There are several factors that can influence the infection rate in Africa. A study from Japan shows that after just 12 days of allowing doctors to legally prescribe Ivermectin to their patients, the number of cases dropped dramatically.45

The Tokyo Medical Association president46 had noted the low rate of infections and deaths in Africa, where many use ivermectin prophylactically and as the core strategy for treating onchocerciasis,47 a parasitic disease also known as river blindness. More than 99% of people infected with river blindness live in 31 African countries.

In addition to the use of ivermectin in Africa, other drugs are widely available, such as hydroxychloroquine and chloroquine, which have long been used in the treatment and prevention of malaria,48 also endemic to Africa.49 In America, Dr. Vladimir Zelenko published successful results with hydroxychloroquine and zinc against COVID-19.50,51,52

Finally, Artemisia annua, also known as sweet wormwood, is an herb used in combination therapies to treat malaria.53 It has been used in traditional Chinese medicine to treat fever for over 2,000 years. Today, artemisinin, a metabolite of Artemisia, is the current therapeutic option for malaria. The plant has also been studied for the treatment of coronaviruses since the SARS outbreak of 2003, with good results.54,55

In other words, whether by design or by default, the drugs that have been proven to be successful against the virus are often used in Africa for other health problems. While Pfizer is testing the short- and long-term effects of a genetic experiment on the Israeli population56, it appears that one continent has shown that administration of a 30-year-old, low-cost drug with a known safety profile could reduce cases, severity and mortality. of this infection.

The question to be asked and answered in order to get to the bottom of this pandemic is what is blinding the mainstream media, government agencies, public health experts, medical associations, doctors, nurses, and your closest neighbor to acknowledge and speak out in support. of science?



This post New Study Confirms Ivermectin Outperforms Other Options

was original published at “http://articles.mercola.com/sites/articles/archive/2022/02/14/ivermectin-outperforms-other-medications.aspx”